Patent directory · USPTO A61K / A61P
Browse patents
Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.
Quick answer
NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.
Patent results
-
US 7741091
Methods of producing hyaluronic acid and chimeric and hybrid glycosaminoglycan polymers
granted -
US 7740889
Bacteriocins and novel bacterial strains
granted -
US 7740867
Method for identification of virulence determinants
granted -
US 7741063
Toxoplasma gondii oocyst protein
granted -
US 7741321
Modulators of ATP-binding cassette transporters
granted -
US 7741304
Casein kinase 2 antisense therapy
granted -
US 7741113
Cell-specific molecule and method for importing DNA into osteoblast nuclei
granted -
US 7741431
Liposomes containing novel targeting and/or fusogenic peptides, preparations containing them and therapeutic use thereof
granted -
US 7737177
Processes for preparing crystalline and amorphous mupirocin calcium
granted -
US 7737183
β-amyloid and neurofibrillary tangle imaging agents
granted -
US 7737118
Rotational intrathecal analgesia
granted -
US 7736656
Immunogenic compositions and vaccines for Ebola
granted -
US 7736646
Methods for modulating angiogenesis with apelin compositions
granted -
US 7737282
Benzimidazole compound crystal
granted -
US 7737266
RNAi modulation of SCAP and therapeutics uses thereof
granted -
US 7737265
RNAi modulation of HIF-1 and therapeutic uses thereof
granted -
US 7737174
Indole inhibitors of MDM2 and the uses thereof
granted -
US 7737151
Pyrazine kinase inhibitors
granted -
US 7737256
Antibody against uPA/uPAR
granted -
US 7737124
Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
granted -
US 7736652
Antibody fusion proteins: effective adjuvants of protein vaccination
granted -
AU 2009324043
Novel composition for treatment of essential thrombocythemia
granted -
US 7732470
Compositions and methods for the treatment of renal and cardiovascular disease
granted -
US 7732445
Myosin light chain kinase inhibitor compounds, compostions and related methods of use
granted
Frequently asked questions
What patents are included in this directory?
We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.
How do I search for a patent?
Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.
How is this different from the patent intelligence dashboard?
The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.